Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.
Sector: In Vitro & In Vivo Diagnostic Substances
Industry: Biotechnology
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 1.34M shares outstanding
GBVirax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases.
The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.
Nigel McCracken
Chief Operating Officer & Director
James Foster
Chairman, Chief Executive Officer & Principal Accounting Officer
Clement Monteil
Head of Scientific Research & Development
Lily Fu
Head of Supply Chain
Employees
26
Country
GB
Sector
Healthcare
Website
viraxbiolabs.com
Loading congressional disclosures…
based on 1.34M shares outstanding
GB30d Avg
203.87K
60d Avg
576.25K
90d Avg
618.85K
